CBG.L vs. CDTX

Last updated Jun 4, 2026

CBG.L (Close Brothers Group plc) and CDTX (Cidara Therapeutics, Inc.) are both stocks. CBG.L operates in Banks - Regional (Financial Services), while CDTX operates in Biotechnology (Healthcare). At a 0.05 correlation, their price movements are largely independent.

Performance

CBG.L vs. CDTX - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Close Brothers Group plc (CBG.L) and Cidara Therapeutics, Inc. (CDTX). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

CBG.L is traded in GBp, while CDTX is traded in USD. To make them comparable, the CDTX values have been converted to GBp using the latest available exchange rates.

Returns By Period

CBG.L

• 1D: -0.58%
• 1M: 1.59%
• YTD: -14.14%
• 6M: 1.45%
• 1Y: 37.61%
• 3Y*: -21.16%
• 5Y*: -19.78%
• 10Y*: -6.62%

CDTX

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CBG.L vs. CDTX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CBG.L Close Brothers Group plc	-14.14%	121.21%	-70.25%	-17.80%	-20.21%	5.65%	-10.18%	16.61%	3.71%	4.36%
CDTX Cidara Therapeutics, Inc.	0.34%	663.22%	72.23%	-0.26%	-33.37%	-35.90%	-49.45%	57.19%	-63.39%	-40.27%

Correlation

The correlation between CBG.L and CDTX is -0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.03
Correlation (3Y) Calculated over the trailing 3-year period	0.01
Correlation (5Y) Calculated over the trailing 5-year period	0.03
Correlation (10Y) Calculated over the trailing 10-year period	0.04
Correlation (All Time) Calculated using the full available price history since Apr 16, 2015	0.05

Fundamentals

Market Cap CBG.L : £671.11M CDTX : $3.44B
EPS CBG.L : -£0.82 CDTX : -$11.88
PB Ratio CBG.L : 0.46 CDTX : 8.15
Total Revenue (TTM) CBG.L : £1.84B CDTX : $0.00
Gross Profit (TTM) CBG.L : £1.58B CDTX : -$45.00M
EBITDA (TTM) CBG.L : £174.70M CDTX : -$189.91M

Return for Risk

CBG.L vs. CDTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CBG.L

CBG.L Risk / Return Rank: 63
CBG.L Sharpe Ratio Rank: 65
CBG.L Sortino Ratio Rank: 64
CBG.L Omega Ratio Rank: 63
CBG.L Calmar Ratio Rank: 62
CBG.L Martin Ratio Rank: 63

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CBG.L vs. CDTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Close Brothers Group plc (CBG.L) and Cidara Therapeutics, Inc. (CDTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CBG.L	CDTX	Difference
Sharpe ratio: Return per unit of total volatility	0.72	—	—
Sortino ratio: Return per unit of downside risk	1.44	—	—
Omega ratio: Gain probability vs. loss probability	1.18	—	—
Calmar ratio: Return relative to maximum drawdown	1.00	—	—
Martin ratio: Return relative to average drawdown	2.36	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	CBG.L	CDTX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.72	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.40	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.16	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.21	—	—

Drawdowns

Drawdown Indicators

	CBG.L	CDTX	Difference
Max Drawdown Largest peak-to-trough decline	-86.76%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-37.33%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-79.97%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-86.55%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-86.76%	—	—
Current Drawdown Current decline from peak	-67.89%	—	—
Average Drawdown Average peak-to-trough decline	-22.65%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	15.88%	—	—

Volatility

Volatility by Period

	CBG.L	CDTX	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.27%	—	—
Volatility (6M) Calculated over the trailing 6-month period	34.37%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	51.74%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	48.98%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	40.23%	—	—

Dividends

CBG.L vs. CDTX - Dividend Comparison

Neither CBG.L nor CDTX has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CBG.L Close Brothers Group plc	0.00%	0.00%	0.00%	8.50%	6.30%	4.27%	2.89%	4.13%	4.38%	4.14%	3.94%	4.00%
CDTX Cidara Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both CBG.L and CDTX in my portfolio?

CBG.L and CDTX have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.